Offer - Urjas Oil for just ₹ 1 X
Britiblu is a prescription medicine that is available as a Drops. The alternative uses of Britiblu have also been explained below.
The correct dosage of Britiblu depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Britiblu are Eye Burning, Eye irritation, Stinging in the Eyes. While these are the most often observed Britiblu side effects, there are can be others also. These have been listed below. Such side effects of Britiblu normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Britiblu is Mild for pregnant women and Unknown for women who are breastfeeding. In addition, Britiblu's effects on the liver, heart and kidney are discussed below in the Britiblu related warnings section.
Britiblu can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Britiblu in conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease). Other conditions have been mentioned below in the Britiblu contraindications section.
Drug interactions for Britiblu have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Britiblu, it is important to know that it is safe while driving, and is habit-forming.
Britiblu is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Britiblu safe for pregnant women?
Pregnant women can consume [medicine]. Though Britiblu has mild side effects when taken during pregnany
Is the use of Britiblu safe during breastfeeding?
Information about safety of Britiblu for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Britiblu on the Kidneys?
There may be some adverse effects on kidney after taking Britiblu. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Britiblu on the Liver?
The liver can be affected by Britiblu. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Britiblu only after medical advice.
What is the effect of Britiblu on the Heart?
You may experience side effects on your heart after taking Britiblu. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Britiblu should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Britiblu unless your doctor advises you to do so -
Is this Britiblu habit forming or addictive?
No, you will not get addicted to Britiblu.
Interaction between Food and Britiblu
Taking Britiblu with food does not harm your health.
Interaction between Alcohol and Britiblu
No research has been done on this till date. Therefore, it is not known what the effect of taking Britiblu with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)